Neuropeptide S Receptor 1 Gene Polymorphism Is Associated With Susceptibility to Inflammatory Bowel Disease

Gastroenterology

Volumn 133, Issue 3, 2007, Pages 808-817

  D'Amato, Mauro ^a   Bruce, Sara ^a   Bresso, Francesca ^a   Zucchelli, Marco ^a   Ezer, Sini ^b,d   Pulkkinen, Ville ^b   Lindgren, Cecilia ^a   Astegiano, Marco ^e   Rizzetto, Mario ^e   Gionchetti, Paolo ^g   Riegler, Gabriele ^h   Sostegni, Raffaello ^f   Daperno, Marco ^f   D'Alfonso, Sandra ⁱ   Momigliano Richiardi, Patricia ⁱ   Torkvist, Leif ^a   Puolakkainen, Pauli ^b   Lappalainen, Maarit ^b,c   Paavola Sakki, Paulina ^b   Halme, Leena ^b   Farkkila, Martti ^b   Turunen, Ulla ^b   Kontula, Kimmo ^b   Lofberg, Robert ^a,j   Pettersson, Sven ^a,k   Kere, Juha ^a,b,d   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c BIOMEDICUM HELSINKI   (Finland)

^d FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^e MOLINETTE HOSPITAL   (Italy)

^f MAURIZIANO HOSPITAL   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

ⁱ UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^j Sophiahemmet Hospital   (Sweden)

^k GENOME INSTITUTE OF SINGAPORE   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S RECEPTOR 1A; NEUROPEPTIDE S RECEPTOR 1B; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; COLON CROHN DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; ENTERITIS; FINLAND; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; ITALY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; ULCERATIVE COLITIS;

EID: 34548535911     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.06.012     Document Type: Article

References (51)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347 (2002) 417-429
2. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3 (2003) 521-533
3. Fedorak R.N., and Madson N.L. Naturally occurring and experimental models of inflammatory bowel disease. 5th ed. (2000), Saunders, Philadelphia 113-143
4. Schreiber S., Rosenstiel P., Albrecht M., et al. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6 (2005) 376-388
5. Kuster W., Pascoe L., Purrmann J., et al. The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am J Med Genet 32 (1989) 105-108
6. Orholm M., Munkholm P., Langholz E., et al. Familial occurrence of inflammatory bowel disease. N Engl J Med 324 (1991) 84-88
7. Meucci G., Vecchi M., Torgano G., et al. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). Gastroenterology 103 (1992) 514-519
8. Tysk C., Lindberg E., Jarnerot G., et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29 (1988) 990-996
9. Cho J.H., Nicolae D.L., Gold L.H., et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A 95 (1998) 7502-7507
10. Hampe J., Schreiber S., Shaw S.H., et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 64 (1999) 808-816
11. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379 (1996) 821-823
12. Rioux J.D., Silverberg M.S., Daly M.J., et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 66 (2000) 1863-1870
13. Satsangi J., Parkes M., Louis E., et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14 (1996) 199-202
14. Gaya D.R., Russell R.K., Nimmo E.R., et al. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet 367 (2006) 1271-1284
15. Laitinen T., Polvi A., Rydman P., et al. Characterization of a common susceptibility locus for asthma-related traits. Science 304 (2004) 300-304
16. Kormann M.S., Carr D., Klopp N., et al. G-protein-coupled receptor polymorphisms are associated with asthma in a large German population. Am J Respir Crit Care Med 171 (2005) 1358-1362
17. Melen E., Bruce S., Doekes G., et al. Haplotypes of G protein-coupled receptor 154 are associated with childhood allergy and asthma. Am J Respir Crit Care Med 171 (2005) 1089-1095
18. Malerba G., Lindgren C.M., Xumerle L., et al. Chromosome 7p linkage and GPR154 gene association in Italian families with allergic asthma. Clin Exp Allergy 37 (2007) 83-89
19. Feng Y., Hong X., Wang L., et al. G protein-coupled receptor 154 gene polymorphism is associated with airway hyperresponsiveness to methacholine in a Chinese population. J Allergy Clin Immunol 117 (2006) 612-617
20. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25 (2001) 402-408
21. Pulkkinen V., Majuri M.L., Wang G., et al. Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses. Hum Mol Genet 15 (2006) 1667-1679
22. Vendelin J., Pulkkinen V., Rehn M., et al. Characterization of GPRA, a novel G protein-coupled receptor related to asthma. Am J Respir Cell Mol Biol 33 (2005) 262-270
23. Barrett J.C., Fry B., Maller J., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
24. Schaid D.J., Rowland C.M., Tines D.E., et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
25. R Development Core Team. R Reference Manual: Base Package. Bristol: Network Theory. 2003.
26. Benjamini Y., and Hocgberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57 (1995) 289-300
27. Reinscheid R.K., Xu Y.L., Okamura N., et al. Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther 315 (2005) 1338-1345
28. Roth A.L., Marzola E., Rizzi A., et al. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. J Biol Chem 281 (2006) 20809-20816
29. Bernier V., Stocco R., Bogusky M.J., et al. Structure/function relationships in the neuropeptide s receptor: molecular consequences of the asthma-associated mutation N107I. J Biol Chem 281 (2006) 24704-24712
30. McGovern D.P., Hysi P., Ahmad T., et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 14 (2005) 1245-1250
31. Brant S.R., Panhuysen C.I., Nicolae D., et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 73 (2003) 1282-1292
32. Ho G.T., Nimmo E.R., Tenesa A., et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 128 (2005) 288-296
33. Schwab M., Schaeffeler E., Marx C., et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124 (2003) 26-33
34. Zheng W., Rosenstiel P., Huse K., et al. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun 7 (2006) 11-18
35. Hugot J.P., Chamaillard M., Zouali H., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
36. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
37. Hampe J., Cuthbert A., Croucher P.J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
38. Stoll M., Corneliussen B., Costello C.M., et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36 (2004) 476-480
39. Peltekova V.D., Wintle R.F., Rubin L.A., et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36 (2004) 471-475
40. Xu Y.L., Reinscheid R.K., Huitron-Resendiz S., et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43 (2004) 487-497
41. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 4 (2004) 978-988
42. Sato S, Shintani Y, Miyajima N, et al. Novel G protein coupled receptor protein and DNA thereof. US patent application WO 02/31145 A1. April 18, 2002.
43. Gupte J., Cutler G., Chen J.L., et al. Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach. Proc Natl Acad Sci U S A 101 (2004) 1508-1513
44. Vendelin J., Bruce S., Holopainen P., et al. Downstream target genes of the neuropeptide S-NPSR1 pathway. Hum Mol Genet 15 (2006) 2923-2935
45. O'Connor T.M., O'Connell J., O'Brien D.I., et al. The role of substance P in inflammatory disease. J Cell Physiol 201 (2004) 167-180
46. Papadakis K.A. Chemokines in inflammatory bowel disease. Curr Allergy Asthma Rep 4 (2004) 83-89
47. Powrie F. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses. Ann N Y Acad Sci 1029 (2004) 132-141
48. Macdonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 (2005) 1920-1925
49. Brogden K.A., Guthmiller J.M., Salzet M., et al. The nervous system and innate immunity: the neuropeptide connection. Nat Immunol 6 (2005) 558-564
50. Bernstein C.N., Wajda A., and Blanchard J.F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129 (2005) 827-836
51. Black H., Mendoza M., and Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 131 (2007) 524-532